ArticlePloS one2025

Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor CRISPR/Cas9 gene correction over knock-out.

Danny Wilbie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.